Steven R. Sarkisian Jr.

Dr. Steven R. Sarkisian, Jr. is the Founder and CEO of Oklahoma Eye Surgeons, PLLC, and the former director of the glaucoma fellowship at the Dean McGee Eye Institute, and clinical professor of ophthalmology at the University of Oklahoma in Oklahoma City. He has a special interest in Minimally Invasive Glaucoma Surgery (MIGS), and premium cataract surgery. He has co-authored the book, “Minimally Invasive Glaucoma Surgery, a Practical Guide.”

Dr. Sarkisian received his MD from Jefferson Medical College in Philadelphia and completed an ophthalmology residency at the State University of New York Health Science Center (SUNY Downstate) in Brooklyn, New York, and did a fellowship in glaucoma at the Hamilton Eye Institute at the University of Tennessee Health Science Center in Memphis.

Dr. Sarkisian has been a PI in most of the seminal clinical trials for glaucoma, including all three generations of the iStent, the TVT study, the ABC study, the ExPress vs Trab study, and the FDA clinical trials for the CyPass implant, the iStent inject and iStent Supra implants and the iDose sustained release travoprost implant and the Bimatoprost sustained-release implant.

Dr. Sarkisian is on the editorial board of the Journal of Cataract and Refractive Surgery, Glaucoma Today, and Glaucoma Physician and is listed in Woodward/White’s Best Doctors in America, Castle and Connolly Top Doctors, and Oklahoma Super Doctors.